Reset
Showing 18 of 18 academic articles

Synergistic Effects of Resveratrol and Temozolomide Against Glioblastoma Cells: Underlying Mechanism and Therapeutic Implications

Liu Y, Song X, Wu M, Wu J et al. • Cancer Management and Research (2020)

Yusi Liu, Xue Song, Moli Wu, Jiao Wu, Jia Liu Liaoning Laboratory of Cancer Genetics and Epigenetics and Department of Cell Biology, College of Basic Medical Sciences, Dalian Medical University, Dalian, People’s Republic of ChinaCorre...

DOAJ Open Access (DOAJ)

Substrate stiffness effect on molecular crosstalk of epithelial-mesenchymal transition mediators of human glioblastoma cells

Bernadette Basilico, Ilaria Elena Palamà, Stefania D’Amone, Clotilde Lauro et al. • Frontiers in Oncology (2022)

The complexity of the microenvironment effects on cell response, show accumulating evidence that glioblastoma (GBM) migration and invasiveness are influenced by the mechanical rigidity of their surroundings. The epithelial–mesenchymal trans...

DOAJ Open Access (DOAJ) DOI: 10.3389/fonc.2022.983507

Metabolic modeling-based drug repurposing in Glioblastoma

Claudio Tomi-Andrino, Alina Pandele, Klaus Winzer, John King et al. • Scientific Reports (2022)

Abstract The manifestation of intra- and inter-tumor heterogeneity hinders the development of ubiquitous cancer treatments, thus requiring a tailored therapy for each cancer type. Specifically, the reprogramming of cellular metabolism has b...

DOAJ Open Access (DOAJ) DOI: 10.1038/s41598-022-14721-w

miRNA-mediated loss of m6A increases nascent translation in glioblastoma.

John P Zepecki, David Karambizi, J Eduardo Fajardo, Kristin M Snyder et al. • PLoS Genetics (2021)

Within the glioblastoma cellular niche, glioma stem cells (GSCs) can give rise to differentiated glioma cells (DGCs) and, when necessary, DGCs can reciprocally give rise to GSCs to maintain the cellular equilibrium necessary for optimal tum...

DOAJ Open Access (DOAJ) DOI: 10.1371/journal.pgen.1009086

Alterations in white matter fiber density associated with structural MRI and metabolic PET lesions following multimodal therapy in glioma patients

Michel Friedrich, Ezequiel Farrher, Svenja Caspers, Svenja Caspers et al. • Frontiers in Oncology (2022)

BackgroundIn glioma patients, multimodality therapy and recurrent tumor can lead to structural brain tissue damage characterized by pathologic findings in MR and PET imaging. However, little is known about the impact of different types of d...

DOAJ Open Access (DOAJ) DOI: 10.3389/fonc.2022.998069

Unrevealing the dual role of paired box and sex determining region Y related high mobility group box in glioblastoma

Kallol Polley, Sayed Mohammed Firdous • Discover Oncology (2026)

Abstract This narrative review summarises glioblastoma (GBM), a very frequent invasive kind of brain tumour in the elderly that is extremely aggressive, resistant to treatment, and has a bad prognosis because of its substantial genetic and ...

DOAJ Open Access (DOAJ) DOI: 10.1007/s12672-026-04671-4

Nanomedicine for Glioblastoma: Cutting-Edge Advances and Persistent Challenges

Ladi Alik Kumar, K Sunand, Jitendra Debata, Gopal Krishna Padhy et al. • Journal of Bio-X Research (2025)

Cancer is a disorder characterized by the abnormal growth of cells that increases uncontrollably over an extended period of time. Treating cancerous brain tumors remains among the most challenging tasks for researchers, as brain tumors are ...

DOAJ Open Access (DOAJ) DOI: 10.34133/jbioxresearch.0065

Immunogenic cell death-related macrophage gene model for prognostic prediction in glioblastoma

Yiming Mao, Ting Li, Wenqiang Lu, Chunhong Li et al. • Discover Oncology (2025)

Abstract Glioblastoma (GBM) is an extremely aggressive and diverse type of brain tumor that is associated with a poor prognosis. Immunogenic cell death (ICD) is a particular form of cellular demise that is closely linked to antineoplastic i...

DOAJ Open Access (DOAJ) DOI: 10.1007/s12672-025-03557-1